Loading company…
Riskpilot
← Back to search
Sign in
Get full access
OPAL INVEST AS
AS
Active
Org 989225413
Hagahaugvegen 12, 5705 Voss
Retail sale of medical and orthopaedic goods · NACE 4774
Est. 2006
3 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 1,3M
+10% vs 2023
EBITDA margin
32.0%
+459% vs 2023
Equity ratio
73.4%
Financial strength
Net profit 2024
NOK 797K
+1% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 1,3M
+10%
EBITDA
NOK 414K
+459%
Net profit
NOK 797K
+1%
Total assets
NOK 25M
+1%
Equity
NOK 18,4M
+2%
Employees
3
—
Company information
Legal name
OPAL INVEST AS
Org number
989225413
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
11. februar 2006
Share capital
NOK 200 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Investera i finans- og realobjekt.
Contact
Address
Hagahaugvegen 12, 5705 Voss
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of medical and orthopaedic goods
Companies in Voss
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
1M
2020
1M
2021
1M
2022
1M
2023
1M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
1 089
1 236
1 407
1 182
1 296
Staff expenses
−281
−156
−246
−248
−237
EBITDA
342
404
241
74
414
Depreciation & amort.
−652
−651
−670
−571
−571
EBIT
−310
−247
−429
−497
−157
Net financials
2 259
1 327
1 291
1 251
932
Profit before tax
1 949
1 080
862
754
775
Tax
33
18
−48
−32
−22
Net profit
1 916
1 062
911
786
797
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
29 707
27 567
25 474
24 860
25 005
Equity
18 396
17 158
18 069
18 055
18 351
Long-term debt
0
0
0
0
0
Short-term debt
2 778
2 633
406
969
1 533
Total debt
11 311
10 409
7 406
6 805
6 653
Financial ratios
5-year trend
EBITDA margin
32.0%
This company
15.8%
Market median
+103% vs market
2020
2024
Equity ratio
73.4%
This company
38.2%
Market median
+92% vs market
2020
2024
Return on equity
4.3%
This company
18.4%
Market median
-77% vs market
2020
2024
Net profit margin
61.5%
This company
8.1%
Market median
+659% vs market
2020
2024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
2020
2024
Debt / equity
0.36×
This company
0.62×
Market median
+42% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
HE
Heidi Ervik Opheim
Deputy Member
Deputy Member
2006
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
AO
Alf Opheim
Chairman
2006
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
OPAL INVEST AS
(this company)
Ha-Mj As
BONANGERGATA 6 AS
Hordaland Optometrie Og Kontaktlinseinstitutt As
OPHEIMSGÅRDEN AS
Board network connections
Board members of OPAL INVEST AS also hold positions in
0
other companies.
Person
Role here
Other companies
Heidi Ervik Opheim
Deputy Member
0 companies
Alf Opheim
Chairman
0 companies